The pharmaceutical company hopes to reap gross proceeds of around $20 million from the offering.
News & Analysis: Cyclacel Pharmaceuticals
These five stocks bucked last week's uptrend by taking a dive.
These five stocks soared over the past few days.
A closer look at today's big market movers
Gilead, Amarin, and Cyclacel are all up over 5%
Unfortunately, there were more of the latter.